Clinical trial Recruiting at 5 sites Observational Ages 18 and up

INTERACT4 Expansion: Seeing if a quick GFAP test can help ID brain bleeds before hospital care

Official title: INTEnsive Ambulance-delivered Blood Pressure Reduction in Biomarker-identified Hyper-ACute Intracerebral Haemorrhage Trial - Validation Study

Run by The George Institute · NCT07231315 · Data updated 2026-11-12

This observational study tests whether a point-of-care GFAP test in pre-hospital care can help identify intracerebral hemorrhage in adults with suspected acute stroke.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment163 (estimated)
SponsorThe George Institute
Academic / other
Locations6 sites (Sydney, New South Wales and 5 other locations)
StatusRecruiting
StartedSeptember 18, 2026
Main results expectedMarch 1, 2027
Study endsJune 1, 2027
Registry record updatedOctober 26, 2026
Trial IDNCT07231315 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older with sudden stroke-like symptoms (FAST ≥2 with arm deficit), within 3 hours of last seen well, and SBP ≥150 mmHg.

Probably not a fit

Patients with coma, severe comorbidities, epilepsy history, recent head injury, or low blood glucose may not benefit from this pre-hospital testing approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an investigator-initiated, multi-centre, open-label, single-arm prospective observational study evaluating the feasibility of setting up a trial that uses a GFAP point-of-care test to identify intracerebral hemorrhage in patients with acute stroke-like symptoms before arrival at the hospital. Eligible participants are adults with suspected stroke within 3 hours of last known well, with high blood pressure and specific motor/face-speech deficits, excluding those with coma, severe comorbidities, epilepsy history, recent head injury, or hypoglycemia. The study is conducted at three sites in New South Wales, led by The George Institute, and uses LVOne as the intervention framework. Primary aim is feasibility of trial conduct and pre-hospital testing workflows. Outcomes will inform larger studies on pre-hospital triage and treatment pathways for stroke patients.

Why it matters

Potential benefit: If feasible, this approach could streamline pre-hospital triage and speed targeted care for intracerebral hemorrhage.

How similar studies have gone: Previous work has explored biomarkers for stroke triage; this study tests feasibility in a pre-hospital setting and is relatively novel in its specific GFAP, pre-hospital context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults (age ≥18 years);
2. Acute syndrome that is due to presumed acute stroke, defined as FAST (Face, Arm, Speech, Time) scores of ≥2 with an arm motor deficit;
3. Time ≤3 hours from last seen well;
4. Systolic BP (SBP) ≥150mmHg.

Exclusion Criteria:

1. Participants in coma (no response to tactile/verbal stimulation); or/and do not respond to "P" or "U" on the alert/verbal/painful/unresponsive (APVU) responsiveness scale;
2. Severe known co-morbid disease (e.g. cancer, chronic airflow disease, severe dementia, severe heart failure, pre-existing disability \[needing help\]);
3. Known history of epilepsy or seizure at onset;
4. Recent head injury (where there is potential for another type of intracranial haemorrhage or head trauma);
5. Hypoglycaemia (glucose\<4.0 mmol/L) as measured in the ambulance.

Where it's running

  • Nepean Hospital
    Sydney, New South Wales, Australia
    Recruiting
  • New South Wales Ambulance
    Sydney, New South Wales, Australia
    Recruiting
  • Royal North Shore Hospital
    Sydney, New South Wales, Australia
    Recruiting
  • St George Hospital
    Sydney, New South Wales, Australia
    Recruiting
  • Wollongong Hospital
    Sydney, New South Wales, Australia
    Recruiting
  • Liverpool Hospital
    Sydney, New South Wales, Australia
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.